Lawood & Co’s CVS Health CVS Stock Holding History

Lawood & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$320K	Hold	3,095	–	–	0.22%	76
2026 Q1	$222K	Sell	3,095 -125	-4%	-$9.63K	0.21%	87
2025 Q4	$256K	Buy	+3,220	New	+$254K	0.24%	81

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Lawood & Co's CVS Position: Q2 2026 in Review

Lawood & Co held its CVS Health (CVS) position steady in Q2 2026 at 3,095 shares worth $320K. The position accounts for 0.22% of the portfolio, ranked #76.

Lawood & Co first reported a position in CVS in Q4 2025 and has held it in 3 quarters since. 2,063 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Lawood & Co held 3,095 shares of CVS Health worth $320K as of Q2 2026.
Lawood & Co left its CVS Health share count unchanged in Q2 2026.
CVS Health made up 0.22% of Lawood & Co's portfolio in Q2 2026, its #76 holding.
Lawood & Co first reported a position in CVS Health in Q4 2025 and has held it in 3 quarters since.
2,063 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Lawood & Co's 13F filing for Q2 2026, filed 13 Jul 2026.